Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07144800 · ClinicalTrials.gov registry record · NA

Family COMIDA (Consumo de Opciones Más Ideales De Alimentos) (Eating More Ideal Food Options)

A NA study of Obesity and Weight Loss, sponsored by Memorial Sloan Kettering Cancer Center.

Recruiting
Registry status
NA
Development phase
1,319
Enrollment target
1
Study location

NCT07144800: Recruiting NA study of Obesity and Weight Loss, sponsored by Memorial Sloan Kettering Cancer Center.

NCT07144800 is a NA study of Obesity and Weight Loss that is actively recruiting participants, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 1,319 participants, above the 818-participant average among 1,053 other Obesity trials with a reported enrollment target (61% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07144800, a NA study of Obesity and Weight Loss, is actively recruiting participants, sponsored by Memorial Sloan Kettering Cancer Center.

RECRUITING
Registry status
NA
Development phase
1,319 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine the most effective family-centered intervention (FCI) for weight loss and obesity prevention in Hispanic families. FCI is a type of program that involves family (such as parents and caregivers) supporting their children to promote healthy habits.

Primary Outcome

To utilize an optimization trial to identify the most effective, mHealth weight loss/obesity prevention FCI for Hispanic families in the U.S. 5% weight loss from baseline among overweight/obese parents (a percentage loss associated with numerous health benefits)

Interventions

  • BEHAVIORAL Parent Weekly Individual Telephone Support
  • BEHAVIORAL Child Education
  • BEHAVIORAL Parent Initial Counseling
  • BEHAVIORAL Parent Monthly Group Support

Study Locations (1)

New York

  • Memorial Sloan Kettering Cancer Center (All Protocol Activities) - New York

Trial Details

FieldValue
Enrollment Target 1,319 participants
Start Date 2025-08-22
Est. Completion 2031-07-31
Phase NA
Memorial Sloan Kettering Cancer Center

1,884 total trials

What NCT07144800 shows while recruiting

NCT07144800 is an interventional study that assigns participants to a tested intervention. Its 1,319 participants enrollment target places it among the larger protocols in the corpus, above the 818-participant average among 1,053 other Obesity trials with a reported enrollment target (61% higher).

The record links to 3 conditions, with Obesity appearing as the primary indexed condition, and to 4 interventions - of which Parent Weekly Individual Telephone Support is the first listed.

NCT07144800 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT07144800 about?

NCT07144800 is a clinical study titled "Family COMIDA (Consumo de Opciones Más Ideales De Alimentos) (Eating More Ideal Food Options)". The purpose of this study is to determine the most effective family-centered intervention (FCI) for weight loss and obesity prevention in Hispanic families. FCI is a type of program that involves family (such as parents and caregivers) supporting their children to promote healthy habits.

What is the current status of trial NCT07144800?

This trial is currently recruiting. It is a NA study. The enrollment target is 1,319 participants. The study started on 2025-08-22. Estimated completion is 2031-07-31.

What conditions does trial NCT07144800 study?

This clinical trial studies the following conditions: Obesity, Weight Loss, Child Obesity.

What interventions are being tested in trial NCT07144800?

The interventions under investigation include: Parent Weekly Individual Telephone Support (BEHAVIORAL), Child Education (BEHAVIORAL), Parent Initial Counseling (BEHAVIORAL), Parent Monthly Group Support (BEHAVIORAL).

Who is sponsoring clinical trial NCT07144800?

This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07144800 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07144800's enrollment target sits among peer trials

1,319 61st of 1053 higher than 993 of 1,053 other Obesity trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT07213908 · 1,320 participants · NA

    Comparing Two School-Based Sleep Health Interventions To Promote Sleep Quality in Youth

  • NCT05762302 · 1,316 participants · NA

    The Impact of MeMed BV® on Management of Patients With Suspected Lower Respiratory Tract Infections (LRTI) in the Emergency Department (ED) and Urgent Care Center (UCC) ("JUPITER" TRIAL)

  • NCT05097287 · 1,324 participants · Phase 4

    Study Assessing the Long-term Effect of Dupilumab on Prevention of Lung Function Decline in Adult Patients With Uncontrolled Moderate to Severe Asthma

  • NCT05176483 · 1,314 participants · Phase 1

    Study of Zanzalintinib in Combination With Immuno-Oncology Agents in Participants With Solid Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07144800, the US trial registry maintained by the National Library of Medicine. NCT07144800 (large enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.